IL6 and neoplasm: Although we identified many similarities between the previously identified tumour promoting cytokine network and cytokine signalling in the MES subtype, IL6 in specific was neither observed in the ligand–receptor analysis nor significantly differentially expressed compared to the other subtypes [11].